O. F. Olmez Et Al. , "The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , vol.49, Amsterdam, Netherlands, 2013
Olmez, O. F. Et Al. 2013. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).
Olmez, O. F., Cubukcu, E., Evrensel, T., KURT, M., Avci, N., Tolunay, S., ... Bekar, A.(2013). The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands
Olmez, O. Et Al. "The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013
Olmez, O. F. Et Al. "The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013
Olmez, O. F. Et Al. (2013) . "The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={O. F. Olmez Et Al. }, title={The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}